scholarly journals US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards

2012 ◽  
Vol 8 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Saul N. Weingart ◽  
Justin W. Li ◽  
Junya Zhu ◽  
Laurinda Morway ◽  
Sherri O. Stuver ◽  
...  
Keyword(s):  
Cancer Center ◽  
Oncology Nursing ◽  
Cancer Centers ◽  
Safety Standards ◽  
Chemotherapy Administration

Given wide variation in the implementation of ASCO/Oncology Nursing Society chemotherapy administration safety standards at US cancer centers, there are significant opportunities for improvement.

American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards

2009 ◽  
Vol 36 (6) ◽  
pp. 651-658 ◽  
Author(s):  
Joseph O. Jacobson ◽  
Martha Polovich ◽  
Kristen K. McNiff ◽  
Kristine B. LeFebvre ◽  
Charmaine Cummings ◽  
...  
Keyword(s):  
Clinical Oncology ◽  
Oncology Nursing ◽  
Safety Standards ◽  
Chemotherapy Administration ◽  
American Society

scholarly journals Chemotherapy Errors: A Call for a Standardized Approach to Measurement and Reporting

2016 ◽  
Vol 12 (4) ◽  
pp. e495-e501 ◽  
Author(s):  
Inga T. Lennes ◽  
Nie Bohlen ◽  
Elyse R. Park ◽  
Elizabeth Mort ◽  
Debra Burke ◽  
...  
Keyword(s):  
General Hospital ◽  
Massachusetts General Hospital ◽  
Safety Monitoring ◽  
Cancer Center ◽  
Oncology Nursing ◽  
Event Reporting ◽  
Safety Reporting ◽  
The Past ◽  
Chemotherapy Administration ◽  
Safety Event

The Massachusetts General Hospital (MGH) Cancer Center is a multidisciplinary cancer center that delivers chemotherapy to 150 to 200 patients daily and adheres to the Oncology Nursing Society and ASCO guidelines for safe chemotherapy administration. An error that occurred at MGH in the summer of 2012 prompted a review of all safety events, the process of classification, and the monitoring of safety events. This article reviews safety monitoring in the oncology setting, details the oncology safety-event reporting program at MGH, summarizes all chemotherapy-related safety events that have occurred over the past 5 years, and concludes with summary recommendations and potential steps to standardize safety reporting and analysis in chemotherapy administration.

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

2016 ◽  
Vol 12 (12) ◽  
pp. 1262-1271 ◽  
Author(s):  
Michael N. Neuss ◽  
Terry R. Gilmore ◽  
Kristin M. Belderson ◽  
Amy L. Billett ◽  
Tara Conti-Kalchik ◽  
...  
Keyword(s):  
Pediatric Oncology ◽  
Stakeholder Participation ◽  
Oncology Nursing ◽  
Extensive Literature ◽  
Periodic Review ◽  
Safety Standards ◽  
Pediatric Hematology ◽  
Additional Information ◽  
Chemotherapy Administration ◽  
American Society

Purpose To update the ASCO/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards and to highlight standards for pediatric oncology. Methods The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. A subsequent 2013 revision expanded the standards to include the safe administration and management of oral chemotherapy. A joint ASCO/ONS workshop with stakeholder participation, including that of the Association of Pediatric Hematology Oncology Nurses and American Society of Pediatric Hematology/Oncology, was held on May 12, 2015, to review the 2013 standards. An extensive literature search was subsequently conducted, and public comments on the revised draft standards were solicited. Results The updated 2016 standards presented here include clarification and expansion of existing standards to include pediatric oncology and to introduce new standards: most notably, two-person verification of chemotherapy preparation processes, administration of vinca alkaloids via minibags in facilities in which intrathecal medications are administered, and labeling of medications dispensed from the health care setting to be taken by the patient at home. The standards were reordered and renumbered to align with the sequential processes of chemotherapy prescription, preparation, and administration. Several standards were separated into their respective components for clarity and to facilitate measurement of adherence to a standard. Conclusion As oncology practice has changed, so have chemotherapy administration safety standards. Advances in technology, cancer treatment, and education and training have prompted the need for periodic review and revision of the standards. Additional information is available at http://www.asco.org/chemo-standards .

scholarly journals Survey of the State of Implementation of the American Society of Clinical Oncology/Oncology Nursing Society Safety Standards for Chemotherapy Administration in India

2015 ◽  
Vol 11 (5) ◽  
pp. 365-369 ◽  
Author(s):  
Vijay M. Patil ◽  
Santam Chakraborty ◽  
Atanu Bhattacharjee ◽  
Sampada Dessai
Keyword(s):  
Clinical Oncology ◽  
National Level ◽  
The State ◽  
Oncology Nursing ◽  
Present Survey ◽  
Safety Standards ◽  
Chemotherapy Administration ◽  
American Society

The present survey indicates that there is an urgent need to formulate national-level guidelines for safe chemotherapy administration.

scholarly journals 2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral Chemotherapy

2013 ◽  
Vol 9 (2S) ◽  
pp. 5s-13s ◽  
Author(s):  
Michael N. Neuss ◽  
Martha Polovich ◽  
Kristen McNiff ◽  
Peg Esper ◽  
Terry R. Gilmore ◽  
...  
Keyword(s):  
Clinical Oncology ◽  
Oral Chemotherapy ◽  
Parenteral Administration ◽  
Oncology Nursing ◽  
Intravenous Chemotherapy ◽  
Good Practices ◽  
Safe Delivery ◽  
Safety Standards ◽  
Chemotherapy Administration ◽  
American Society

Chemotherapy providers have generally developed and implemented good practices around the safe delivery of intravenous chemotherapy. Nonetheless, practices applying for QOPI certification usually modify or expand one or more processes to meet standards for safe parenteral administration.

Multidisciplinary optimization of oral chemotherapy delivery at the UW Carbone Cancer Center.

2016 ◽  
Vol 34 (7_suppl) ◽  
pp. 58-58
Author(s):  
Daniel Mulkerin ◽  
Mary Mably ◽  
Jason Bergsbaken ◽  
Kari Schuhmacher ◽  
Chris Nemergut ◽  
...  
Keyword(s):  
Gap Analysis ◽  
Oral Chemotherapy ◽  
Multidisciplinary Optimization ◽  
Cancer Center ◽  
Safety Standards ◽  
Institutional Practice ◽  
Caregiver Education ◽  
Chemotherapy Administration ◽  
Partial Compliance ◽  
Order Sets

58 Background: Use of oral chemotherapy is expanding and offers advantages but introduces unique safety challenges. ASCO and ONS addressed these issues with inclusion of oral chemotherapy in published chemotherapy administration safety standards. Methods: The updated ASCO/ONS standards offered a framework for the University of Wisconsin Carbone Cancer Center to evaluate and improve our practice with the goal of full compliance with these standards. Gap analysis revealed noncompliance with five and partial compliance with eleven standards. We divided areas for improvement into three foci: patient education, workflow, and information technology. Multidisciplinary groups addressed each area generating twenty-five recommendations. Important changes included: defining chemotherapy, standardization of patient and caregiver education, mandated use of standardized electronic order sets incorporating safety checks, and standardizing dose modification documentation. The revised electronic process allows for prospective order review of all oral chemotherapy by pharmacists and supports automated processes for assessing adherence and toxicities utilizing a library of scripted drug specific materials. Results: Prior to implementation of new processes we estimated that only 39% of our oral chemotherapy was delivered with potential demonstrable compliance with ASCO/ONS standards. Audit of oral chemotherapy orders from February to July 2015 now shows compliance with use of electronic chemotherapy plans in 244/251 (97.5%) of cases. Prospective pharmacist order review resulted in one or more interventions in 24% of these cases.Identification of patients to receive adherence and toxicity monitoring calls is 100%. Conclusions: Closure of significant gaps between institutional practice and published standards was accomplished for our oral chemotherapy practice. Key elements of success included: multidisciplinary approach, defining chemotherapy, leveraging our electronic health record with mandated use of standardized order sets, and standardization of clinical and educational processes. We are disseminating this approach across our regional network and we believe our tools are broadly applicable.

Sign in / Sign up

Export Citation Format

Share Document